Publications - James A. Martenson Jr., M.D.

Back to research profile

  1. Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai TH, Stien KJ, Martenson JA Jr. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013 Apr; 21(4):1193-9. Epub 2012 Nov 15.
    View PubMed
  2. Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, Alberts SR, Heimbach JK. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012 Sep; 56(3):972-81. Epub 2012 Jul 17.
    View PubMed
  3. Hallemeier CL, Iott MJ, Martenson JA, Haddock MG, Zhao XC, Miller RC. A Pilot Study Examining Circulating Interleukin-6 and Transforming Growth Factor-beta Levels During Pelvic Radiation Therapy. Am J Clin Oncol. 2012 Jul 03. [Epub ahead of print]
    View PubMed
  4. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012 Jul 1; 30(19):2327-33. Epub 2012 May 14.
    View PubMed
  5. Chakravarthy AB, Catalano PJ, Martenson JA, Mondschein JK, Wagner H, Mansour EG, Talamonti MS, Benson AB. Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e607-13. Epub 2011 Apr 20.
    View PubMed
  6. Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL, Burger KN, Martenson JA, Miller RC. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81(2):397-402. Epub 2010 Oct 01.
    View PubMed
  7. Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1460-6. Epub 2010 Aug 26.
    View PubMed
  8. Kachnic LA, Winter K, Wasserman T, Kelsen D, Ginsberg R, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Willett CG, Minsky BD. Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer. Gastrointest Cancer Res. 2011 Mar; 4(2):45-52.
    View PubMed
  9. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02.
    View PubMed
  10. Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus. 2008; 21(3):241-50.
    View PubMed
  11. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, Tschetter LK, Moore DF Jr, Fitch TR, Alberts SR, North Central Cancer Treatment Group (N0044). Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol. 2007 Oct; 30(5):507-13.
    View PubMed
  12. Haddock MG, Swaminathan R, Foster NR, Hauge MD, Martenson JA, Camoriano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DF Jr, Alberts SR. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol. 2007 Jun 20; 25(18):2567-72.
    View PubMed
  13. Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB, Chari ST, Martenson JA. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc. 2007 May; 82(5):628-37.
    View PubMed
  14. Haddock MG, Sloan JA, Bollinger JW, Soori G, Steen PD, Martenson JA, North Central Cancer Treatment Group. Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial. J Clin Oncol. 2007 Apr 1; 25(10):1255-9.
    View PubMed
  15. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  16. Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB 3rd, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol. 2006 Aug 1; 24(22):3542-7.
    View PubMed
  17. Justice TE, Martenson JA, Wiseman GA, Witzig TE. Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy. Cancer. 2006 Jul 15; 107(2):433-8.
    View PubMed
  18. Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006 Feb 1; 24(4):635-42.
    View PubMed
  19. Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA Jr. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2004 Dec 1; 60(5):1510-4.
    View PubMed
  20. Jatoi A, Martenson J, Mahoney MR, Lair BS, Brindle JS, Nichols F, Caron N, Rowland K, Tschetter L, Alberts S. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. Int Semin Surg Oncol. 2004 Nov 08; 1(1):9.
    View PubMed
  21. Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B, Benson AB 3rd, Myerson R, Goldberg RM. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol. 2004 Aug 15; 22(16):3277-83. Epub 2004 Jul 12.
    View PubMed
  22. Benson AB, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA, McCallum R, Mitchell EP, O'Dorisio TM, Vokes EE, Wadler S. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004 Jul 15; 22(14):2918-26.
  23. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004 May 15; 22(10):1785-96. Epub 2004 Apr 05.
    View PubMed
  24. Lavertu S, Schild SE, Gunderson LL, Haddock MG, Martenson JA. Endocavitary radiation therapy for rectal adenocarcinoma: 10-year results. Am J Clin Oncol. 2003 Oct; 26(5):508-12.
    View PubMed
  25. Kozelsky TF, Meyers GE, Sloan JA, Shanahan TG, Dick SJ, Moore RL, Engeler GP, Frank AR, McKone TK, Urias RE, Pilepich MV, Novotny PJ, Martenson JA, North Central Cancer Treatment Group. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol. 2003 May 1; 21(9):1669-74.
    View PubMed
  26. Martenson JA, Vigliotti AP, Pitot HC, Geeraerts LH, Sargent DJ, Haddock MG, Ghosh C, Keppen MD, Fitch TR, Goldberg RM. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2003 Apr 1; 55(5):1305-10.
    View PubMed
  27. Gunderson LL, Sargent DJ, Tepper JE, O'Connell MJ, Allmer C, Smalley SR, Martenson JA, Haller DG, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Goldberg RM. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):386-96.
    View PubMed
  28. Miller RC, Sargent DJ, Martenson JA, MacDonald JS, Haller D, Mayer RJ, Gunderson LL, Rich TA, Cha SS, O'Connell MJ. Acute diarrhea during adjuvant therapy for rectal cancer: A detailed analysis from a randomized intergroup trial. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):409-13.
    View PubMed
  29. Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB, Cummings B, Gunderson LL, Macdonald JS, Martenson JA, Mayer RJ. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol. 2002 Apr 1; 20(7):1744-50.
    View PubMed
  30. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002 Mar 1; 20(5):1167-74.
    View PubMed
  31. Smalley SR, Gunderson L, Tepper J, Martenson JA Jr, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002 Feb 1; 52(2):283-93.
    View PubMed
  32. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001 Sep 6; 345(10):725-30.
    View PubMed
  33. Stafford SL, Kozelsky TF, Garrity JA, Kurtin PJ, Leavitt JA, Martenson JA, Habermann TM. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001 May; 59(2):139-44.
    View PubMed
  34. Martenson JA, Bollinger JW, Sloan JA, Novotny PJ, Urias RE, Michalak JC, Shanahan TG, Mailliard JA, Levitt R. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol. 2000 Mar; 18(6):1239-45.
    View PubMed
  35. Fonseca R, Habermann TM, Colgan JP, O'Neill BP, White WL, Witzig TE, Egan KS, Martenson JA, Burgart LJ, Inwards DJ. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000 Jan 1; 88(1):154-61.
    View PubMed
  36. Brown PD, Stafford SL, Schild SE, Martenson JA, Schiff D. Metastatic spinal cord compression in patients with colorectal cancer. J Neurooncol. 1999 Sep; 44(2):175-80.
    View PubMed
  37. Martenson JA, Shanahan TG, O'Connell MJ, Cobau CD, Schroeder G, Burch PA, Levitt R, Rowland KM Jr. Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy. Cancer. 1999 Aug 15; 86(4):710-4.
    View PubMed
  38. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL. Chemoradiotherapy of locally advanced esophageal cancer - long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA. 1999 May 5; 281(17):1623-1627.
    View PubMed
  39. Miller AR, Martenson JA, Nelson H, Schleck CD, Ilstrup DM, Gunderson LL, Donohue JH. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys. 1999 Mar 1; 43(4):817-25.
    View PubMed
  40. Miller RC, Martenson JA, Sargent DJ, Kahn MJ, Krook JE. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys. 1998 Jun 1; 41(3):593-8.
    View PubMed
  41. Stafford SL, Martenson JA. Combined radiation and chemotherapy for carcinoma of the anal canal. Oncology (Williston Park). 1998 Mar; 12(3):373-7, 381; discussion 382, 384, 38.
    View PubMed
  42. Haddock MG, Martenson JA Jr. Anal carcinoma. Cancer Treat Res. 1998; 98:201-25.
    View PubMed
  43. Tepper JE, O'Connell MJ, Petroni GR, Hollis D, Cooke E, Benson AB 3rd, Cummings B, Gunderson LL, Macdonald JS, Martenson JA. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol. 1997 May; 15(5):2030-9.
    View PubMed
  44. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, Fieck JM, Wolff B, Dozois R, O'Connell MJ. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. Int J Radiat Oncol Biol Phys. 1997 Feb 1; 37(3):601-14.
    View PubMed
  45. Martenson JA, Swaminathan R, Burch PA, Santala RG, Schroeder G, Pitot HC, Wright K, Kugler JW, Stella PJ, Garton GR. Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer. Int J Radiat Oncol Biol Phys. 1997 Feb 1; 37(3):615-8.
    View PubMed
  46. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock MG, Devine RM, Fieck JM, Wolff BG, Dozois RR, O'Connell MJ. Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FU. Front Radiat Ther Oncol. 1997; 31:204-8.
    View PubMed
  47. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, Fieck JM, Wolff B, Dozois R, O'Connell MJ. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum. 1996 Dec; 39(12):1379-95.
    View PubMed
  48. Martenson JA, Lipsitz SR, Wagner H Jr, Kaplan EH, Otteman LA, Schuchter LM, Mansour EG, Talamonti MS, Benson AB 3rd. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996 Jul 1; 35(4):745-9.
    View PubMed
  49. Martenson JA Jr, Hyland G, Moertel CG, Mailliard JA, O'Fallon JR, Collins RT, Morton RF, Tewfik HH, Moore RL, Frank AR, Urias RE, Deming RL. Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys. 1996 May 1; 35(2):299-303.
    View PubMed
  50. Gunderson LL, Martenson JA, Haddock MG. Indications for and results of irradiation +/- chemotherapy for rectal cancer. Ann Acad Med Singapore. 1996 May; 25(3):448-59.
    View PubMed
  51. Schild SE, Martenson JA, Gunderson LL. Endocavitary radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):677-82.
    View PubMed
  52. Wong WW, Schild SE, Martenson JA. Role of radiation therapy and fluoropyrimidines in the treatment of gastrointestinal malignancies. Cancer Control. 1996; 3(4):319-328.
    View PubMed
  53. Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG. Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study. Cancer. 1995 Nov 15; 76(10):1731-6.
    View PubMed
  54. Martenson JA Jr, Urias R, Smalley SR, Coia LR, Tepper JE, Rotman M, Rich TA, O'Connell MJ. Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):51-5.
    View PubMed
  55. Gunderson LL, Nagorney DM, Martenson JA, Donohue JH, Garton GR, Nelson H, Fieck J. External beam plus intraoperative irradiation for gastrointestinal cancers. World J Surg. 1995 Mar-Apr; 19(2):191-7.
    View PubMed
  56. Suzuki K, Gunderson LL, Devine RM, Weaver AL, Dozois RR, Ilstrup DM, Martenson JA, O'Connell MJ. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer. 1995 Feb 15; 75(4):939-52.
    View PubMed
  57. Durr ED, Bonner JA, Strickler JG, Martenson JA, Chen MG, Habermann TM, Donohue JH, Earle JD, Grill JP. Management of stage IE primary gastric lymphoma. Acta Haematol. 1995; 94(2):59-68.
    View PubMed
  58. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg. 1994 Nov; 220(5):676-82.
    View PubMed
  59. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994 Aug 25; 331(8):502-7.
    View PubMed
  60. Martenson JA Jr, Schutt AJ, Grado GL, Maples WJ, Marschke RF Jr. Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer. Int J Radiat Oncol Biol Phys. 1994 Jan 15; 28(2):439-43.
    View PubMed
  61. Moertel CG, Gunderson LL, Mailliard JA, McKenna PJ, Martenson JA Jr, Burch PA, Cha SS. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol. 1994 Jan; 12(1):21-7.
    View PubMed
  62. Gunderson LL, Martenson JA, Smalley SR, Garton GR. Lower gastrointestinal cancers: rationale, results, and techniques of treatment. Front Radiat Ther Oncol. 1994; 28:140-54.
    View PubMed
  63. Gunderson LL, Martenson JA, Smalley SR, Garton GR. Upper gastrointestinal cancers: rationale, results, and techniques of treatment. Front Radiat Ther Oncol. 1994; 28:121-39.
    View PubMed
  64. Gschossmann JM, Bonner JA, Foote RL, Shaw EG, Martenson JA Jr, Su J. Malignant tracheoesophageal fistula in patients with esophageal cancer. Cancer. 1993 Sep 1; 72(5):1513-21.
    View PubMed
  65. Shaw EG, Bonner JA, Foote RL, Martenson JA Jr, Frytak S, Deschamps C, McDougall JC. Role of radiation therapy in the management of lung cancer. Mayo Clin Proc. 1993 Jun; 68(6):593-602.
    View PubMed
  66. Gunderson LL, Nagorney DM, McIlrath DC, Fieck JM, Wieand HS, Martinez A, Pritchard DJ, Sim F, Martenson JA, Edmonson JH, et al. External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1993 Mar 15; 25(4):647-56.
    View PubMed
  67. Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer. 1993 Mar 1; 71(5):1736-40.
    View PubMed
  68. Garton GR, Gunderson LL, Webb MJ, Wilson TO, Martenson JA Jr, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience. Gynecol Oncol. 1993 Mar; 48(3):328-32.
    View PubMed
  69. Foo ML, Gunderson LL, Nagorney DM, McIllrath DC, van Heerden JA, Robinow JS, Garton GR, Martenson JA Jr, Cha SS. Patterns of failure in totally resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/-5-fluorouracil. Int J Radiat Oncol Biol Phys. 1993; 26:483-9.
    View PubMed
  70. Minehan KJ, Martenson JA Jr, Garrity JA, Kurtin PJ, Banks PM, Chen MG, Earle JD. Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment. Int J Radiat Oncol Biol Phys. 1991 Apr; 20(4):791-6.
    View PubMed
  71. Gunderson LL, Martenson JA, Kvols LK, Devine RM, Beart RW. Indications for and results of intraoperative irradiation for locally advanced colorectal cancer. Front Radiat Ther Oncol. 1991; 25:284-306; discussion 330-3.
    View PubMed
  72. Schild SE, Martenson JA Jr, Gunderson LL, Ilstrup DM, Berg KK, O'Connell MJ, Weiland LH. Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors. Int J Radiat Oncol Biol Phys. 1989 Jul; 17(1):55-62.
    View PubMed
  73. Schild SE, Martenson JA Jr, Gunderson LL, Dozois RR. Long-term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 1989 Feb; 16(2):459-63.
    View PubMed
  74. Gunderson LL, Martenson JA Jr. Gastrointestinal tract radiation tolerance. Front Radiat Ther Oncol. 1989; 23:277-98; discussion 299-301.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.